Fort Sheridan Advisors’s Lineage Cell Therapeutics LCTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$50.1K Hold
2025
Q1
$24.9K Hold
2024
Q4
$27.7K Buy
2024
Q3
$29.1K Hold
2024
Q2
$32.1K Hold
2024
Q1
$47.6K Sell
2023
Q4
$44.6K Sell
2023
Q3
$99K Hold
2023
Q2
$118K Buy
2023
Q1
$111K Sell
2022
Q4
$98.2K Hold
2022
Q3
$95K Buy
2022
Q2
$125K Buy
2022
Q1
$117K Buy
2021
Q4
$130K Buy
2021
Q3
$121K Hold
2021
Q2
$137K Buy
2021
Q1
$106K Buy